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RESEARCH ARTICLE
Virulence of viral haemorrhagic 
septicaemia virus (VHSV) genotype III 
in rainbow trout
Takafumi Ito1*, Jun Kurita1, Koh‑ichiro Mori2 and Niels J. Olesen3
Abstract 
In general, viral haemorrhagic septicaemia virus (VHSV) isolates from marine fish species in European waters (geno‑
types GIb, GII and GIII) are non‑ to low virulent in rainbow trout. However, a VHSV isolation was made in 2007 from a 
disease outbreak in sea farmed rainbow trout in Norway. The isolate, named NO‑2007‑50‑385, was demonstrated to 
belong to GIII. This isolate has attracted attention to assess which of the viral genome/proteins might be associated 
with the virulence in rainbow trout. In this study, we describe the difference of virulence in rainbow trout between 
the NO‑2007‑50‑385 and 4p168 isolates as representatives of virulent and non‑virulent GIII isolates, respectively. 
Rainbow trout were bath challenged with VHSV NO‑2007‑50‑385 for 1 and 6 h, resulting in cumulative mortalities of 5 
and 35%, respectively. No mortality was observed in the rainbow trout groups immersed with the genotype III VHSV 
isolate 4p168 for 1 and 6 h. The viral titre in organs from fish challenged with NO‑2007‑50‑385 for 6 h increased more 
rapidly than those exposed for 1 h. By in vitro studies it was demonstrated that the final titres of VHSV DK‑3592B (GI), 
NO‑2007‑50‑385 and 4p168 inoculated on EPC cells were very similar, whereas when inoculated on the rainbow trout 
cell line RTG‑2 the titre of the non‑virulent 4p168 isolate was 3–4 logs below the two other VHSV isolates. Based on a 
comparative analysis of the entire genome of the genotype III isolates, we suggest that substitutions of amino acids in 
positions 118–123 of the nucleo‑protein are candidates for being related to virulence of VHSV GIII in rainbow trout.
© 2016 Ito et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Viral haemorrhagic septicaemia virus (VHSV) is known 
as the causative agent of serious diseases occurring in 
wild and farmed fish in the Northern Hemisphere. Until 
the beginning of the 1990’s the disease was believed to 
cause severe mortalities only in farmed rainbow trout in 
Continental Europe. In the last three decades, however, 
VHSV has been isolated from more than 80 fresh- and 
seawater fish species in North America, North East Asia 
and Europe [1–4].
VHSV isolates can be divided into four major geno-
types and a number of subtypes with rather distinct geo-
graphical distributions [5–7]. The host range and the 
pathogenicity appear, at least to some extent, to be linked 
to the genotype. In general, VHSV isolated from marine 
fishes (genotypes GIb, GII, GIII and GIVa) are non- or 
low virulent for rainbow trout Oncorhynchus mykiss [8]. 
Several research groups have searched for traits deter-
mining virulence mechanisms of VHSV [9–11]. Béar-
zotti et  al. reported that the glycoprotein (G)-protein 
seemed to play an important role in the virulence to 
rainbow trout [9]. Snow and Cunningham reported that 
the virulence by rainbow trout of the VHSV GIII iso-
late UK-860/94, which was isolated from an outbreak in 
farmed turbot, increased after five in vivo passages [10]. 
In this study, the viral G-gene sequences were examined 
for all five passages, resulting in 100% similarity. From 
the results of comparison of the virulent isolates DK-
Hededam (GI) and FR-14-58 (GIa) with the two non-
virulent GIb isolates, UK-96-43 and Cod ulcus virus 
(synonym: M Rhabdo), Betts and Stone [11] suggested 
that only a limited number of changes in various viral 
proteins may be involved in whether an isolate becomes 
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pathogenic or not. However, identification of which of 
the amino acid (aa) substitutions play the most important 
role for VHSV virulence remains elusive in rainbow trout. 
Since the viral G-protein is responsible for the produc-
tion of neutralizing antibodies in fish [12–14], and has 
been suggested to play an important role in determining 
the virulence of VHSV [9, 15], specific mutations in the 
G-protein have been considered interesting. However, in 
a recent report, Kim et  al. [16] showed that a substitu-
tion at position 1012 of the large polymerase (l)-protein 
of VHSV can change the virulence to rainbow trout gill 
epithelial cells. In addition Einer-Jensen et  al. reported 
that differences in virulence among phylogenetically dis-
tinct isolates of VHSV are not explained by variability of 
the G-protein or the non-virion (Nv) protein [17]. These 
reports suggest that other viral proteins than the G- and 
Nv-protein may have a role in determining the virulence 
of VHSV in rainbow trout.
Stone et  al. [15] argued that marine isolates of VHSV 
are a potential threat to the fish farming industry if the 
opportunity to adapt under intensive farming conditions 
is provided. An isolation of VHSV was made in 2007 
from a disease outbreak in sea farmed rainbow trout in 
Norway. The isolate, named NO-2007-50-385, was dem-
onstrated to belong to GIII [18]. Since in general GIII iso-
lates have been found to be non- or having only very low 
virulence to rainbow trout [8], this isolate has attracted 
attention in order to assess which of the viral genome or 
proteins might be associated with the induction of viru-
lence in rainbow trout. Duesund et al. [19] reported the 
full genome sequence of the virulent VHSV GIII isolate 
FA281107 (which is equivalent to NO-2007-50-385 in the 
Fish Pathogens Database [20]), and they concluded that 
the lack of information about the entire genome of the 
low virulent VHSV GIII isolates is a major problem for 
the study of the virulence factors of this virus.
In our previous studies, VHSV genotype specific mAbs 
were produced in order to establish a fast and low cost 
system for genotyping VHSV isolates [21, 22]. In the 
process, we encountered several unpredicted reactions. 
The VHS-3.75 mAb, reacts with all genotype III iso-
lates except with the rainbow trout pathogenic isolate 
NO-2007-50-385 (from the Norwegian west coast) [18], 
and additionally reacted with the GIVc isolate, CA-NB00-
01, (from the American east coast, New Brunswick) [23]. 
By aa alignment of the nucleo (N)-protein, the epitope of 
this mAb was found to include amino acids at positions 
103, 118 and 121 [22]. The atypical reaction of this mAb 
could thus be related to the virulence of the isolate to 
rainbow trout. There was, however, no sequence infor-
mation on the entire genome of VHSV GIII isolates with 
low virulence to rainbow trout, and thereby this epitopic 
part of the mAb VHS-3.75 could not be determined as 
the only domain responsible for virulence of VHSV GIII 
isolates in rainbow trout.
In this study, we describe the differences of pathogenic-
ity in rainbow trout between the virulent NO-2007-50-
385 and the non-virulent 4p168 VHSV GIII isolates. In 
addition, the few differences in the nucleotide compo-
sition of the full genome of the isolates are described 
and discussed. The resulting alignments indicate that 
substitutions of the 3 aa in the N-protein can be related 
virulence of VHSV GIII in rainbow trout. Moreover, we 
demonstrated that the non-virulent 4p168 isolate rep-
licated to a lower titre in a rainbow trout cell line when 
compared to virulent isolates and to cell lines from other 
fish species, and we documented that the duration of 
exposure is crucial when describing virulence in infection 
by immersion trials.
Materials and methods
Virus and cell lines
The VHSV GIII isolates used for the present study were 
NO-2007-50-385 [18] and 4p168 [24], representing a 
rainbow trout virulent and a non-virulent isolate, respec-
tively. In addition, the very high virulent rainbow trout 
VHSV Ia isolate DK-3592B was used as a positive control 
[25].
The bluegill fry (BF-2) cell line [26] was used for prop-
agation, re-isolation and titration of the virus in organs 
from infected fish. This cell line as well as the Epitheli-
oma papulosum cyprini (EPC) [27] and the rainbow trout 
gonadal (RTG-2) [28] cell lines were used to test their 
susceptibility towards infection with the VHSV isolates. 
The cell lines were maintained in minimum essential 
medium (MEM; Mediatech) supplemented with 10% FBS 
(Equitech-Bio) and antibiotics (100 IU/mL penicillin and 
100  μg/mL streptomycin). The cultivation of BF-2 and 
EPC cells was conducted at 25 °C, while the RTG-2 cells 
were cultivated at 20  °C. Each virus isolate was propa-
gated in 75  cm2 flasks (Greiner Bio-One) at 15  °C. The 
viral supernatant was aliquoted into 3.6  mL cryo tubes 
(Nunc™, Thermo Scientific) and stored at −85  °C until 
use. Before the experimental infections, the virus in one 
of the aliquots was quantified by end-point titration in 
96-well plates (Corning). Propagation, re-isolation and 
titration of all isolates were conducted at 15 °C.
Fish
Rainbow trout for both experimental infections were 
bred from VHSV, IHNV and IPNV free broodstocks at 
the Tamaki Laboratory of the National Research Institute 
of Aquaculture (NRIA), Fisheries Research Agency. The 
obtained eggs were disinfected with iodophor (200 mg/L, 
15 min) after fertilization. Fry of rainbow trout were fed 
commercial crumble diets (Ayutech, Marinetech, Japan) 
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until 10–21  days after hatching and were subsequently 
fed commercial pellets (Saki-Hikari®, Kyorin, Japan). All 
stages were maintained in well water at approximately 
15–16 °C to prevent any infection.
Experimental infection
The experimental design for the two infection studies 
is shown in Table  1. In experimental infection #1, 200 
rainbow trout were used (sizes are shown in the table). 
The rainbow trout were divided into 10 groups of 20 fish 
each. Rainbow trout in two groups (40 fish) were infected 
with the DK-3592B isolate as positive control; fish in one 
of the groups were intraperitoneally (i.p.) injected with 
0.1 mL supernatant of crude virus (105.0TCID50/fish); in 
the other group fish were infected by immersion in 105.0 
TCID50 DK-3592B/mL at 13 °C well water for 1 h. Three 
groups were infected with the NO-2007-50-385 isolate; 
one group was i.p. injected with 0.1  mL supernatant of 
crude virus (105.0 TCID50/fish); the other two groups were 
bath infected by immersion in 105.0 TCID50 NO-2007-50-
385/mL water at 13  °C for 1 and 6 h, respectively. Like-
wise, three groups were infected with the VHSV 4p168 
isolate. Two groups were used as non-infected negative 
controls. One group was i.p. injected with 0.1 mL super-
natant from non-infected BF-2 cell cultures. The other 
group was immersed in cell culture supernatant diluted 
1:1000 in well water for 1 h at 13 °C. All injected fish were 
anaesthetized using 2-phenoxyethanol diluted 1:1000 
in well water. All fish groups were kept in 60 L tanks at 
13.2  °C (13.0–13.8  °C) and fed a commercial diet once 
a day. Mortality was observed for 46 days. All dead and 
surviving fish were collected and all samples were tested 
on cell cultures and by reverse transcription-PCR (RT-
PCR). Samples of kidney and spleen were pooled from 
each fish, while the brains were sampled individually.
In experimental infection #2, 225 rainbow trout were 
used (sizes are shown in Table 1). The fish were divided 
into 11 groups of 20–21 fish each. Forty-one rainbow 
trout (two groups) were infected with DK-3592B isolate; 
both groups were bath infected by immersion for 1 h in 
13 °C water at a viral concentration of 105.0 TCID50/mL. 
Eighty-two rainbow trout (four groups) were infected 
with the NO-2007-50-385 isolate; fish in two of the 
groups were bath infected by immersion for 1 h in 13 °C 
well water at a viral concentration of 105.0 TCID50/mL; 
fish in the two other groups were immersed for 6 h in the 
same concentration of virus. Likewise, eighty-two rain-
bow trout (four groups) were infected by immersion with 
the 4p168 isolate for 1 and 6 h, respectively. The remain-
ing group was immersed with supernatant from non-
infected BF-2 cell cultures diluted 1:1000 in well water for 
6  h. Samples for sequential determination of viral titres 
in the fish were collected from one of the two replicate 
tanks in all five infected groups. The other replicate tanks 
Table 1 Experimental design, and the initial total length and body weight of rainbow trout used in this study.
Experiment Group (genotype) Treatment (infectious route/negative control) No. of samples Total length (cm) Body weight (g)
1 DK‑3592B (Ia) Intraperitoneal injection 20 8.96 ± 0.94 9.61 ± 2.53
Immersion 1 h 20 6.12 ± 0.79 2.79 ± 0.73
NO‑2007‑50‑385 (III) Intraperitoneal injection 20 9.10 ± 0.78 9.00 ± 2.48
Immersion 1 h 20 6.35 ± 0.88 2.91 ± 0.81
Immersion 6 h 20 6.59 ± 0.85 3.20 ± 0.93
4p168 (III) Intraperitoneal injection 20 9.28 ± 0.44 9.12 ± 1.88
Immersion 1 h 20 6.62 ± 0.64 3.24 ± 0.78
Immersion 6 h 20 6.77 ± 0.67 3.33 ± 0.82
Negative control Intraperitoneal injection 20 9.52 ± 0.59 9.97 ± 1.74
Immersion 1 h 20 6.75 ± 0.48 3.49 ± 0.55
2 DK‑3592B (Ia) Immersion 1 h (for mortality observation) 20 6.19 ± 0.64 3.14 ± 0.79
Immersion 1 h (for sampling) 21 5.72 ± 0.47 2.17 ± 0.65
NO‑2007‑50‑385 (III) Immersion 1 h (for mortality observation) 20 6.42 ± 1.20 3.51 ± 0.87
Immersion 1 h (for sampling) 21 5.84 ± 0.63 2.25 ± 0.60
Immersion 6 h (for mortality observation) 20 6.56 ± 0.76 3.22 ± 1.17
Immersion 6 h (for sampling) 21 6.07 ± 0.64 2.63 ± 0.85
4p168 (III) Immersion 1 h (for mortality observation) 20 6.67 ± 0.46 3.44 ± 0.66
Immersion 1 h (for sampling) 21 5.98 ± 0.68 2.40 ± 0.82
Immersion 6 h (for mortality observation) 20 6.66 ± 0.48 3.17 ± 0.80
Immersion 6 h (for sampling) 21 5.96 ± 0.89 2.42 ± 1.08
Negative control Immersion 6 h 20 6.57 ± 0.34 3.23 ± 0.46
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were used for observation of mortalities. All fish groups 
were kept in 60 L tanks at 13.7 °C (13.1–14.0 °C) and fed 
a commercial diet once a day, and mortality was observed 
for 29 days after infection. All pooled samples of kidneys 
and spleen, and brain from both dead and surviving fish 
in the tanks used for mortality observation were tested 
for VHSV on cell cultures and by RT-PCR. In addition, 
the gills, brain, heart and kidney from 3 fish from each 
tank used for retrieving samples were collected on days 
1, 3, 5, 7 and 13 after viral exposure as also were organs 
from fish that died in these tanks during the trial. All 
samples were subjected to viral titrations on cell cul-
tures. All fish experiments and the handling of fish were 
in accordance with “Guidelines for Animal Experimenta-
tion” of the National Research Institute of Aquaculture, 
Fisheries Research Agency, Japan. Details of the experi-
mental design, average total length and body weight of 
fish in each group at the initial stage of the challenge are 
also shown in Table 1.
Virus re‑isolation and titration of organs from experimental 
fish
At the end of experiment #1 all fish were sampled for 
virological examination to detect the presence or absence 
of virus, whereas in experiment #2 only samples from 1 
of the 2 replicates were collected (observation group). 
Whole fish were kept at −85  °C until further process-
ing. After thawing, two samples were produced from 
each fish consisting of (1) kidney and spleen tissue, and 
(2) brain tissue. Homogenates of kidney/spleen and brain 
were prepared using approximately 50-times volume of 
MEM and filtered (0.45 μm). Then 100 and 10 μL of the 
each filtrate were inoculated onto subconfluent 1  day-
old BF-2 cells in 24-well culture plates and incubated at 
15  °C. The cells were regularly observed for cytopathic 
effect (CPE) over a period of 14 days. The observation of 
CPE was considered a VHSV positive result.
In cases where the amount of virus was quantified in 
individual organs, the gills, brains, hearts and kidneys were 
weighed, homogenized and then diluted 1:50 in MEM 
before filtration (0.45 μm). The titrations were performed in 
96-well plates (Corning, NY, USA) on BF-2 cells, in 10-fold 
dilutions (four replicates per dilution, and incubated at 
15  °C for 2  weeks). The results are given as TCID50/g 
organ. Samples that did not give CPE were shown as 0 (not 
detected). Positive samples with titres under the detection 
limit for titration was given as <101.3 TCID50/g organ.
Reverse transcription polymerase chain reaction (RT‑PCR)
All fish, both infected and non-infected, were tested by 
RT-PCR. Total RNA was extracted from the samples 
using the TRIzol® Reagent (Life Technologies) following 
the recommended protocol. The total RNA was dissolved 
in 100  μL DNase/RNase-free distilled water (Life Tech-
nologies) and stored at −85  °C until further processing. 
For the RT-PCR, the SuperScript® One-Step RT-PCR 
System with Platinum® Taq (Life Technologies) was used. 
The RT-PCR was performed using the specific primers 
and the thermocycling profile for VHSV described in the 
chapter on VHS of the Manual of Diagnostic Tests for 
Aquatic Animals [29], with the exception that the volume 
was scaled-down from 50 to 20 μL.
Statistical analysis
In experimental infections #1 and #2, the Fisher’s test 
was used to compare cumulative mortality between each 
infection group and negative control group. Statistical 
significance was determined, at p < 0.01.
Multiplication of the three VHSV isolates in various cell 
lines
The multiplication in various cell lines of the three 
VHSV isolates (DK-3592B, NO-2007-50-385 and 4p168) 
was assessed by titration on BF-2, EPC and RTG-2 cell 
lines. Titration was performed by the endpoint dilution 
method, and the results expressed as TCID50/mL. To 
ensure experimental reproducibility, two batches (sample 
A and B) of each virus cell culture supernatant were used.
Sequencing the 4p168 isolate
The viral genome of isolate 4p168 was sequenced as fol-
lows: the VHSV isolate was concentrated and sucrose 
gradient purified as described by Nishizawa et  al. [30]. 
Viral RNA was extracted from the purified virus using 
the ISOGEN-LS® (NIPPON GENE), and subjected to RT-
PCR amplification with primers designed according to 
the sequence of strain FA281107 (GIII) (GenBank acces-
sion no. EU481506) for sequencing of each gene (Addi-
tional file 1). The entire nucleotide sequence of the coding 
region (from N to L gene) of the genome was determined 
by direct sequencing of each RT-PCR products. The 3′ 
termini was cloned using primer 5′-CTC GAT GAT GAT 
GAT GAT CTC-3′ [31] and the TOPO® TA Cloning® Kit 
(Life Technologies) with SURE 2 SuperCompetent Cells 
(Agilent Technologies). The 5′ termini was cloned using 
SMARTer™ RACE cDNA Amplification Kit (Clontech) 
and pGEM®-T Easy Vector Systems (Promega). For all 
nucleotide sequencing, BigDye® Terminator v3.1 Cycle 
Sequencing Kit (Life Technologies) and ABI PRISM® 
3100 Genetic Analyzer (Life Technologies) were used.
Results
Infection experiment 1
The cumulative mortalities in rainbow trout injected with 
VHSV DK-3592B (GIa), NO-2007-50-385 and 4p168 were 
65, 20 and 0%, respectively (Figure  1A). The cumulative 
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mortality observed in rainbow trout immersed with DK-
3592B for 1  h was 75%. Rainbow trout bath challenged 
with NO-2007-50-385 for 1 and 6 h, resulted in cumula-
tive mortalities of 15 and 20%, respectively. No mortality 
was observed in the rainbow trout immersed with 4p168 
for 1 and 6  h. No mortality was observed in the nega-
tive control group (Figure  1A; Table  2). The mortalities 
in the groups infected with DK-3592B by i.p. injection 
(p < 0.0001) and 1 h immersion (p < 0.0001) were signifi-
cantly higher than the negative control group.
VHSV was re-isolated from all the brain and most of the 
kidney/spleen samples collected from rainbow trout that 
died due to infection with DK-3592B and NO-2007-50-385 
(Table 2). From the fish that survived infection by immer-
sion for 1 and 6 h with NO-2007-50-385, VHSV was re-
isolated from 3 out of 33 (3/33) brain samples and in 1/33 
kidney/spleen samples. No VHSV was isolated from any of 
the fish that survived exposure to DK-3592B or 4p168, or 
from any of the non-exposed control fish.
VHSV was detected by RT-PCR from most brain and 
kidney/spleen samples collected from rainbow trout 
dying due to infection with DK-3592B and NO-2007-50-
385 (Table 2). No VHSV was detected by RT-PCR in any 
of the samples from fish that survived VHSV infections 
except for 1/17 brain samples from the fish surviving 1 h 
immersion with NO-2007-50-385 (Table 2).
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Figure 1 Cumulative mortalities in experimental infection #1 and #2. A Experiment #1. B Experiment #2. Asterisk the mortality rate at the 
end of the experiment was significantly different from the negative control (p < 0.01 by Fisher’s exact test).
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Infection experiment 2
In infection trial #2, a cumulative mortality of 65% was 
observed in rainbow trout immersed with DK-3592B 
for 1 h (Table 2; Figure 1B). Cumulative mortalities of 
5 and 35% were observed in rainbow trout bath chal-
lenged with NO-2007-50-385 for 1 and 6  h, respec-
tively. No mortality was observed in rainbow trout 
immersed with 4p168 for 1 and 6 h, or in the negative 
control group. The mortalities in the group infected 
with DK-3592B (p  <  0.0001) and NO-2007-50-385 by 
immersion for 6 h (p < 0.005) were significantly higher 
than the negative control group. In addition, the mor-
talities in the group infected by 1  h immersion with 
NO-2007-50-385 were significantly lower than the 
group infected with DK-3592B (p  <  0.0001) and 6  h 
immersion with NO-2007-50-385 (p < 0.05).
VHSV was re-isolated from all the kidney/spleen and 
brain samples from fish that died due to infection with 
DK-3592B and NO-2007-50-385 (Table  2). In addition 
VHSV was re-isolated from 5/32 kidney/spleen and 7/32 
brain samples from fish surviving infection with NO-2007-
50-385. The frequency of re-isolation of virus from brain 
samples was slightly higher than from the kidney/spleen 
samples. VHSV was not isolated from any of the fish 
infected with 4p168 or from the non-infected control fish.
VHSV was detected by RT-PCR in all of the brain and 
most of the kidney/spleen samples from fish that died due 
to DK-3592B and NO-2007-50-385 infection. Viral RNA 
was not detected by RT-PCR in any of the samples from 
surviving fish infected with 4p168 or from any of the non-
infected control fish, but was detected in 6/32 brain sam-
ples from fish infected with NO-2007-50-385 (Table 2).
Sequential titration of VHSV from fish sampled 
in experiment 2
Examination of sacrificed fish
The sequential viral titres in gill, brain, heart and kidney 
from surviving fish after infection by immersion with 
DK-3592B and NO-2007-50-85 are shown in Table 3. No 
virus was detected in the fish infected with 4p168 iso-
late at any time sampled, and therefore those results are 
not shown in the Table 3. VHSV could be detected from 
the gills (103.5 TCID50/g), heart (103.6 TCID50/g) and kid-
ney (<101.3 TCID 50/g) in 1 of the 3 DK-3592B infected 
fish sacrificed 1 dpe. Virus under the limit of titration 
was also detected in gills from another fish 1 dpe to 
DK-3592B. No virus was detected in any fish 1 day after 
infection with the other two viruses. At 3 dpe, virus was 
detected in gills from 1 fish, brain and heart from 2 fish, 
and kidney from all the 3 fish sacrificed in the DK-3592B 
Table 2 VHSV detection by  reverse-transcription PCR and  virus re-isolation in  cell cultures inoculated with  organs 
from  fish that  died during  the experimental observation period, or those that  survived and  were harvested at  46 dpe 
for experiment 1, and 29 dpe for experiment 2.
Experiment Group  
(genotype)
Treatment 
(infectious 
route/ 
negative 
control)
Cumulative 
mortality  
(%)
Dead fish (no. of positive fish/no. of tested 
fish)
Surviving fish (no. of positive fish/no. of 
tested fish)
Kidney + spleen Brain Kidney + spleen Brain
Virus  
re‑isolation
RT‑PCR Virus  
re‑isolation
RT‑PCR Virus  
re‑isolation
RT‑PCR Virus  
re‑isolation
RT‑PCR
1 DK‑3592B (Ia) IP 65 12/13 11/13 13/13 9/13 0/7 0/7 0/7 0/7
Immersion 1 h 75 15/15 14/15 15/15 15/15 0/5 0/5 0/5 0/5
NO‑2007‑50‑
385 (III)
IP 20 3/4 3/4 4/4 4/4 0/16 0/16 0/16 0/16
Immersion 1 h 15 2/3 2/3 3/3 3/3 1/17 0/17 2/17 1/17
Immersion 6 h 20 3/4 3/4 4/4 4/4 0/16 0/16 1/16 0/16
4p168 (III) IP 0 – – – – 0/20 0/20 0/20 0/20
Immersion 1 h 0 – – – – 0/20 0/20 0/20 0/20
Immersion 6 h 0 – – – – 0/20 0/20 0/20 0/20
Negative 
control
IP 0 – – – – 0/20 0/20 0/20 0/20
Immersion 1 h 0 – – – – 0/20 0/20 0/20 0/20
2 DK‑3592B (Ia) Immersion 1 h 65 13/13 12/13 13/13 11/13 0/7 0/7 1/7 1/7
NO‑2007‑50‑
385 (III)
Immersion 1 h 5 1/1 1/1 1/1 1/1 2/19 0/19 4/19 3/19
Immersion 6 h 35 7/7 7/7 7/7 7/7 3/13 0/13 3/13 3/13
4p168 (III) Immersion 1 h 0 – – – – 0/20 0/20 0/20 0/20
Immersion 6 h 0 – – – – 0/20 0/20 0/20 0/20
Negative 
control
Immersion 6 h 0 – – – – 0/20 0/20 0/20 0/20
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group. In the 6  h immersion NO-2007-50-385 group, 
virus was detected in the brain, heart and kidney from 
2 of 3 fish. At five dpe to DK-3592B, VHSV was detected 
in most of the organs from the three sacrificed fish, 
except from the brain of 1 fish. The titres, ranging from 
103.9 to 109.4 TCID50/g, were in most cases higher than 
in samples collected earlier. In samples collected 5 dpe 
from 3 NO-2007-50-385 1  h immersion infected fish, 
virus was detected in all the organs from 1 of 3 fish, and 
was detected in the gill, brain and kidney from another 
fish. In the fish immersed 6  h with NO-2007-50-385, 
virus was detected in all tested organs from 1 of 3 fish, 
and was detected in the gill and heart from another fish. 
The virus was detected in the 4 organs from the 3 fish 
sacrificed 7 dpe with DK-3592B, except in the brain of 
2 fish. In the fish sacrificed 7 dpe in the NO-2007-50-
385 1 h group, VHSV was detected in kidney with a titre 
of 104.1 TCID50/g, and in gill from one fish with a titre 
under the limit of titration. In the case of the 6 h immer-
sion NO-2007-50-385 fish, virus titre was detected in all 
the organs tested from 1 fish. Virus was detected 13 dpe 
in all organs tested from the two sacrificed fish infected 
with DK-3592B. At this point no virus was detected in 
the three fish collected from the group infected with 
NO-2007-50-385 for 1 h, and was detected in heart from 
1 fish and in all organs from another of the three fish 
examined 13 dpe for 6  h with NO-2007-50-385. On 20 
dpe, VHSV was only detected in the brain from 2 of the 
3 sacrificed fish in the NO-2007-50-385 1 h immersion 
group, whereas all other samples were negative.
Examination of mortalities in infection trial 2
The viral titres in gill, brain, heart and kidney from fish 
that died due to infection with the VHSV isolates are 
shown in Table 4. First mortalities were observed 6, 7 and 
12 dpe to DK-3592B, NO-2007-50-385 1 h and NO-2007-
50-385 6  h, respectively. VHSV was detected in the 4 
tested organs from all examined fish. The median titres 
were 106.4, 105.6, 108.0 and 106.8 TCID50/g in gill, brain, 
heart and kidney, respectively. The heart showed the 
highest titres in 9 of 11 fish, and brain the lowest in 10 of 
11 fish.
Multiplication of VHSV genotype III in fish cell lines
Multiplication of the isolates DK-3592B, NO-2007-
50-385 and 4p168 in three different cell lines is shown 
in Table  5. No remarkable differences were observed 
between the three VHSV isolates in the BF-2 and EPC 
cell lines. But the titre of the non-virulent VHSV isolate 
4p168 in the rainbow trout cell line RTG-2 was 3–4 logs 
lower than the two virulent VHSV isolates, and it was 
also lower than the 4p168 titres attained in BF-2 and EPC 
cells.
Comparative analysis of amino acid (aa) alignments
For comparative analysis of aa substitution sites 
between rainbow trout non-virulent and virulent VHSV 
genotype III isolates, the whole genome sequence of the 
low virulent isolate 4p168 was sequenced and submit-
ted to DDBJ as accession no. AB672616. The entire aa 
sequence of 4p168 was aligned with the aa sequence 
of the virulent GIII isolate. Since FA281107 [19] is 
synonym to NO-2007-50-385, the N- (AB675945) and 
G-protein (EU547740) of NO-2007-50-385 and the P, 
M, Nv and L-gene/protein of FA281107 (EU481506) 
were used to represent a virulent GIII isolate for com-
parison with those of the non-virulent 4p168 isolate. 
As a result, 5 aa substitutions in the N-protein, 1 in the 
phospho (P)-protein, 2 in the matrix (M)-protein, 1 in 
the G-protein, 2 in the Nv-protein and 9 substitutions 
in the L-protein were detected (Table 6; Figure 2; Addi-
tional file 2).
Discussion
This paper is the first report of a direct comparison 
between 2 VHSV Genotype III isolates of different viru-
lence to rainbow trout. The studies included compara-
tive infection trials, cell culture susceptibility tests and 
analysis of the amino acid sequences of the entire viral 
genome. In fact, the complete genome sequencing of the 
non-virulent 4p168 isolate must be considered an impor-
tant achievement in this study. We have demonstrated 
that the length of the exposure to the virus by immersion 
is important for the level of mortality in the infection tri-
als. In addition, we have suggested that only 3 aa substi-
tutions in the N-protein are enough for modulating the 
virulence of VHSV GIII isolates in rainbow trout.
Dale et  al. [18] reported that the isolate NO-2007-50-
385 was highly virulent for rainbow trout by i.p. injection 
and immersion. However, this study did not include com-
parisons with other VHSV GIII isolates known to be low 
or non-virulent to rainbow trout [8]. However the two 
infection trials of the present study have corroborated 
those findings by demonstrating moderate virulence of 
NO-2007-50-385 and non-virulence of 4p168 to rainbow 
trout. Moreover, it was shown that the mortality induced 
by NO-2007-50-385 depended on the time of exposure 
by immersion, clearly in experiment #2. By conducting 
sequential titrations of a number of organs from fish sac-
rificed during trial #2, it was shown that virus titres in fish 
exposed for 6 h raised more quickly and persisted for longer 
than in fish exposed for 1 h. These results indicate that the 
time of exposure to VHSV has a significant effect on the 
virulence to the fish. The low mortality and the low virus 
re-isolation rate in the group exposed 1 h to NO-2007-50-
385 may suggest that the innate immunity mechanisms of 
the fish were more successful at controlling the quantity of 
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Table 3 Sequential titration of  VHSV in  the gills, brain, and  kidney of  fish sampled at  pre-determined time points 
in experiment 2, after exposure by immersion to various VHSV isolates.
Days post exposure Group Individual no. TCID50/g organ
Gill Brain Heart Kidney
1 DK‑3592B 1 103.5 0a 103.6 <101.3b
2 0 0 0 0
3 <101.3 0 0 0
NO‑2007‑50‑385 1 h 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
NO‑2007‑50‑385 6 h 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
3 DK‑3592B 1 0 0 0 <101.3
2 0 <101.3 104.2 105.3
3 103.9 <101.3 104.9 106.0
NO‑2007‑50‑385 1 h 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
NO‑2007‑50‑385 6 h 1 0 0 0 0
2 0 <101.3 103.6 107.2
3 0 104.7 105.9 107.1
5 DK‑3592B 1 108.1 106.8 109.4 109.3
2 106.9 105.9 108.2 107.5
3 103.9 0 105.1 103.9
NO‑2007‑50‑385 1 h 1 106.9 105.1 108.1 107.6
2 104.0 103.7 0 <101.3
3 0 0 0 <101.3
NO‑2007‑50‑385 6 h 1 105.9 107.3 107.2 107.7
2 103.2 0 105.2 0
3 0 <101.3 0 0
7 DK‑3592B 1 105.9 10 4.9 108.2 106.2
2 104.1 0 106.8 104.5
3 103.6 0 106.3 103.6
NO‑2007‑50‑385 1 h 1 0 0 0 0
2 0 0 0 0
3 <101.3 0 0 104.1
NO‑2007‑50‑385 6 h 1 <101.3 0 <101.3 0
2 104.9 10 6.0 107.0 106.5
3 0 0 0 0
13 DK‑3592B 1 108.3 <101.3 108.2 104.0
2 105.7 104.7 107.6 106.0
NO‑2007‑50‑385 1 h 1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
NO‑2007‑50‑385 6 h 1 0 0 <101.3 0
2 104.5 <101.3 105.1 105.1
3 0 0 0 0
20 NO‑2007‑50‑385 1 h 1 0 0 0 0
2 0 103.1 0 0
3 0 103.6 0 0
NO‑2007‑50‑385 6h 1 0 0 0 0
2 0 0 0 0
a 0, Not detected
b <101.3, Positive but under limit for titration (<101.3 TCID 50/g)
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infectious virus that gained entry during the shorter expo-
sure. In general, although the viral concentration in aqua-
culture is lower than under experimental infection, the fish 
will be exposed to virus for a long time. Therefore, when 
the virulence of a virus isolate is studied, the time of expo-
sure seem to play a significant role and should be taken into 
consideration.
The highest titres were observed in heart, indicating 
that it is important to collect this organ when examining 
fish for VHSV. On the other hand it appears that the virus 
in later stages will hide in the brains of a small number 
of surviving fish exposed to NO-2007-50-385 (Table  2). 
In a previous study on the virulence of VHSV genotype 
IVb isolates to a number of different fish species, VHSV 
was detected in the brain from some of the surviving fish, 
and not detected in pooled samples of kidney/spleen 
[32]. Iida et  al. [33] reported that VHSV GIVa was iso-
lated only from the brain and heart of Japanese flounder 
6 weeks post immersion challenge. This study also indi-
cates that VHSV is retained in the brain when compared 
to kidney and spleen in late stages of the infections.
Compared with RT-PCR a few more samples were positive 
by virus isolation. The discrepancy may be caused by differ-
ences in the quantity of sample included in each method. A 
recent validation of a new real time RT-PCR [34] also showed 
lower sensitivity of this conventional RT-PCR method in 
comparison to virus isolation and real time RT-PCR assay.
Previous studies on mammal rhabdoviruses, have suc-
cessfully identified virulence determinants of rabies virus, 
whereby a few point mutations of aa within the G-protein 
was sufficient to have a dramatic impact on the virulence 
[35, 36]. These studies demonstrate the significant impact 
the G-protein in effecting virulence, it also emphasizes the 
notion that only a few aa substitutions are necessary to deter-
mine virulence amongst rhabdoviruses for a prescribed host.
With regard to VHSV virulence determinants for rain-
bow trout, Béarzotti et al. [9] and Stone et al. [15] reported 
that the G-protein seems to play an important role in the 
virulence of VHSV to rainbow trout. The G-protein is 
also responsible for development of neutralizing antibod-
ies and is the only viral protein that can induce protective 
immunity in fish [12, 37]. Neutralization of VHSV infec-
tivity to cell cultures and fish by monoclonal antibodies 
against the viral G-protein has been demonstrated [12, 
14, 37]. Therefore, it was assumed that determinants for 
virulence in rainbow trout should be found in this gene, 
and several reports have been focused on comparative 
studies of the G-protein in high- and non-virulent isolates 
[10, 11]. However, no clear results have been provided 
yet pointing at which substitutions of nucleotide and/or 
amino acid in the G-gene/protein of VHSV are a key for 
triggering pathogenicity in fish. Recent reports [16, 17] 
suggest that any non G-gene/protein may have a role as 
virulence determinants to rainbow trout as well.
Table 4 Titration of VHSV in the gill, brain, heart and kidney of fish that died during experiment 2.
Group Days post exposure Individual no. TCID50/g organ
Gill Brain Heart Kidney
DK‑3592B 6 1 107.3 105.7 108.8 107.2
7 1 105.8 105.0 107.6 106.9
8 1 105.8 104.8 107.3 104.7
10 1 104.4 104.1 108.0 106.4
11 1 104.4 103.8 108.3 106.5
12 1 105.9 103.8 107.7 106.0
NO‑2007‑50‑385 1 h 7 1 106.6 106.5 106.6 107.6
18 1 104.8 103.7 105.5 104.5
NO‑2007‑50‑385 6 h 12 1 105.9 104.6 107.9 104.9
13 1 105.4 104.7 106.0 106.2
19 1 105.6 104.3 108.0 106.0
Median titres 106.4 105.6 108.0 106.8
Table 5 Titration of VHSV isolates in 3 cell lines.
Isolates  
(genotype)
Titre (TCID50/mL)
BF‑2 EPC RTG‑2
Sample  
A and B
Sample  
A and B
Sample  
A and B
DK‑3592B (GIa) 108.8, 109.3 109.3, 109.0 108.3, 108.3
NO‑2007‑50‑385 
(GIII)
107.8, 107.8 108.0, 107.8 107.3, 107.3
4p168 (GIII) 108.6, 108.0 108.0, 107.8 103.8, 104.3
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From the comparative analysis of all protein coding 
regions from rainbow trout non-virulent and virulent 
VHSV genotype III isolates, only one aa substitution in 
the G-protein was demonstrated and at substitution, at 
position aa 47, does not seem to be related with virulence 
in rainbow trout, since the aa in this position of both, the 
high virulent isolate DK-3592B and the non-virulent isolate 
4p168, is serine. Determinants of virulence in rainbow trout 
should thus be found elsewhere than in the viral G-protein.
Based on the reaction patterns with mAb VHS-3.75 
and aa alignments of the full genome sequences of 
VHSV GIII, we suggest that substitutions of aa in the 
Table 6 Comparative analysis of amino acid.
Amino acid (aa) substitution among the VHSV GIII isolates with different virulence properties in rainbow trout (4p168 vs NO-2007-50-385 or FA281107)
Protein Product size (aa) Substitution (n) Identity (%) Substituted (aa) Substitution position (AA)
N 404 5 98.8 T‑K, Q‑L, T‑A, D‑N, N‑S 77, 109, 118, 121, 123
P 222 1 99.6 P‑T 43
M 201 2 99.0 H‑Y, D‑E 72, 111
G 507 1 99.8 S‑A 47
Nv 122 2 98.4 R‑C, E‑D 108, 110
L 1984 9 99.5 A‑T, L‑F, T‑A, R‑K, D‑E, 145, 198, 217, 976, 996,
I‑F, T‑I, D‑G, V‑A 1012, 1105, 1635, 1805
N-protein (aa 51-100)
T77K
P-protein (aa 1-50)
P43T
N-protein (aa 101-150)
T118A, D121N, N123SQ109L
M-protein (aa 1-50)
H72Y
M-protein (aa 101-150)
D111E
G-protein (aa 1-50)
S47A
Nv-protein (aa 101-122)
R108C, E110D
DK-3592B (Ia) 51  DALSALGGPQ  TVQALSVLLS  VVLQGNTQED  LETKCKVLTD  MGFKVTQAVR 100
M Rhabdo (Ib) 51  DALSALGGPQ  TVQALSVLLS  VVLQGNTQED  LGMKCKVLTD  MGFKVTQAAR 100
SE-SVA-14-3D (Ib) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNTQED  LGMKCKVLTD  MGFKVTQAAR 100
SE-SVA-14-5G (Ib) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNTQED  LGMKCKVLTD  MGFKVTQAAR 100
SE-SVA-1033-3F (Ib) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNTQED  LGMKCKVLTD  MGFKVTQAAR 100
SE-SVA-1033-9C (Ib) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNTQED  LGMKCKVLTD  MGFKVTQAAR 100
4p101 (III) 51  DALAALGGPQ  TVQALSVLLS  VVLQGNTQED  LEAKCKVLTD  MGFRVTQSTR 100
4p168 (III) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNTQED  LEAKCKVLTD  MGFRVTQSTR 100
NO-2007-50-385 (III) 51  DALSALGGPQ  TVQALSVLLS  YVLQGNKQED  LEAKCKVLTD  MGFRVTQSTR 100
DK-3592B (Ia) 101  ATSIEAGIMM  PMRELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
M Rhabdo (Ib) 101  ATSIEAGIMM  PMRELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
SE-SVA-14-3D (Ib) 101  ATSIEAGIMM  PMRELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
SE-SVA-14-5G (Ib) 101  ATSIEAGIMM  PMGELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
SE-SVA-1033-3F (Ib) 101  ATSIEAGIMM  PMRELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
SE-SVA-1033-9C (Ib) 101  ATSIEAGIMM  PMRELALTVN  DDNLMEIVKG  TLMTCSLLTK  YSVDKMIKYI 150
4p101 (III) 101  ATGIDAGILM  PMRELALTVN  DDNLMDIVKG  TLMTCSLLTK  YSVDKMIK-- 150
4p168 (III) 101  ATGIDAGIQM  PMRELALTVN  DDNLMDIVKG  TLMTCSLLTK  YSVDKMIKYI 150
NO-2007-50-385 (III) 101  ATGIDAGILM  PMRELALAVN  NDSLMDIVKG  TLMTCSLLTK  YSVDKMIKYI 150
DK-3592B (Ia) 1  MADIEMSESL  VLSHGSLADL  DKRLDNAPKD  NRSALFSSTS  GSTRQKSSPK 50
M Rhabdo (Ib) 1  MADIEMSESL  VLSHGSLADL  DKKLDNAPKD  NRSALFSSPS  ESTRQKSSPK 50
SE-SVA-14-3D (Ib) 1  MADIEMSESL  VLSHGSLADL  DKKLDNAPKD  NRSALFSSPS  ESTRQKSSPK 50
SE-SVA-14-5G (Ib) 1  MADIEMSESL  VLSHGSLADL  DKKLDNAPKD  NRSALFSSPS  ESTRQKSSPK 50
SE-SVA-1033-3F (Ib) 1  MADIEMSESL  VLSHGSLADL  DKKLDNAPKD  NRSALFSSPS  ESTRQKSSPK 50
SE-SVA-1033-9C (Ib) 1  MADIEMSESL  VLSHGSLADL  DKKLDNAPKD  NRSALFSSPS  ESTRQKSSPK 50
4p168 (III) 1  MADIEMSESL VLSHGSLADL DRKLDNAPKD  TRSALFSSTS  GFPKQKSSPK 50
FA281107 (III) 1  MADIEMSESL  VLSHGSLADL  DRKLDNAPKD  TRSALFSSTS  GFTKQKSSPK 50
(NO-2007-50-385)
DK-3592B (Ia) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
M Rhabdo (Ib) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
SE-SVA-14-3D (Ib) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
SE-SVA-14-5G (Ib) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
SE-SVA-1033-3F (Ib) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
SE-SVA-1033-9C (Ib) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
4p168 (III) 51  AMKLARAILC  EDQHPAFNPL  VHLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
FA281107 (III) 51  AMKLARAILC  EDQHPAFNPL  VYLFQSAMIF  GETSEKIDFG  TRSKTLITSF 100
(NO-2007-50-385)
DK-3592B (Ia) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
M Rhabdo (Ib) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
SE-SVA-14-3D (Ib) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
SE-SVA-14-5G (Ib) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
SE-SVA-1033-3F (Ib) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
SE-SVA-1033-9C (Ib) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFI  FADDHVGGKG 150
4p168 (III) 101  KIAEAKAIYL  DSSPVRSRIE  AKKYTTPIRH  GSVTYYGPFV FADDHVGGKG 150
FA281107 (III) 101  KIAEAKAIYL  ESSPVRSRIE  AKKYTTPIRH  GSVTYYGPFV FADDHVGGKG 150
(NO-2007-50-385)
DK-3592B (Ia) 1  MEWNTFFLVI LIIIIKSTTP  QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
M Rhabdo (Ib) 1  MEWNTFFLVI  LIIIIKSTTP  QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
SE-SVA-14-3D (Ib) 1  MEWNTFFLVI LIIIIKSTTP QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
SE-SVA-14-5G (Ib) 1  MEWNTFFLVI  LIIIIKSTTP  QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
SE-SVA-1033-3F (Ib) 1  MEWNTFFLVI  LIIIIKSTTP  QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
SE-SVA-1033-9C (Ib) 1  MEWNTFFLVI  LIIIIKSTTP  QITQRPPVEN  ISTYHADWDT  PLYTHPSNCR 50
4p101 (III) 1  MEWNTFFLVI  LIILIKSTTS QITQRPPTEN  ISTYHADWDT  PLYTHPANCR 50
4p168 (III) 1  MEWNTFFLVI  LIILIKSTTS QITQRPPIEN  ISTYHADWDT  PLYTHPSNCR 50
NO-2007-50-385 (III) 1  MEWNTFFLVI  LIILIKSTTS QITQRPPIEN  ISTYHADWDT  PLYTHPANCR 50
DK-3592B (Ia) 101  PELVIISHAE  VGLLTRGSGL  PS-------- ---------- ---------- 150
M Rhabdo (Ib) 101  PGLIIISHAE  VGLLTSGSGL  TS-------- ---------- ---------- 150
SE-SVA-14-3D (Ib) 101  PGLIIISHAE  VGILTSGSGL  TS-------- ---------- ---------- 150
SE-SVA-14-5G (Ib) 101  PGLIIISHAE  VGILTSGSGL  TS-------- ---------- ---------- 150
SE-SVA-1033-3F (Ib) 101  PGLIIISHAE  VGILTSGSGL  TS-------- ---------- ---------- 150
SE-SVA-1033-9C (Ib) 101  PGLIIISHAE  VGILTSGSGL  TS-------- ---------- ---------- 150
4p168 (III) 101  PGLIIISRAE  VGVLTNGSGF TS-------- ---------- ---------- 150
FA281107 (III) 101  PGLIIISCAD VGVLTNGSGF TS-------- ---------- ---------- 150
(NO-2007-50-385)
I1012F
DK-3592B (Ia) 101  VSKYYLSLGY  TLPPKDKFEF  REVAPYWNLA  SQLREVTLES  QKVDVRGKEK 150
M Rhabdo (Ib) 101  VSKYYLSLGY  TLPPKDKFEF  REVAPYWNLA  SQLREVTLES  QKVDARGKGK 150
SE-SVA-14-3D (Ib) 101  VSKYYLSLGY  TLPPKDKFEF  REVAPYWNLA  SQLREVTLES  QKVDARGKGK 150
SE-SVA-14-5G (Ib) 101  VSKYYLSLGY  TLPPKDKFEF  REVAPYWNLA  SQLREVTLES  QKVDARGKGK 150
SE-SVA-1033-3F (Ib) 101  VSKYYLSLGY TPPPKDKFEF REVAPYWNLA SQLREVTLES  QKVDARGKGK 150
SE-SVA-1033-9C (Ib) 101  VSKYYLSLGY  TLPPKDKFEF  REVAPYWNLA  SQLREVTLES  QKVDARGKGK 150
4p168 (III) 101  VSKYYLSLGY  TLPPKDKFDF  REVAPYWNLA  SQLREVTLES  QKVDARGKEK 150
FA281107 (III) 101  VSKYYLSLGY  TLPPKDKFDF  REVAPYWNLA  SQLREVTLES  QKVD RGKET K 150
(NO-2007-50-385)
DK-3592B (Ia) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FLGGAKLGAV  TYVEYLALFK 200
M Rhabdo (Ib) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FLGGAKLGAV  TYVEYLALFK 200
SE-SVA-14-3D (Ib) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FLGGAKLGAV  TYVEYLALFK 200
SE-SVA-14-5G (Ib) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FLGGAKLGAV  TYVEYLALFK 200
SE-SVA-1033-3F (Ib) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FLGGAKLGAV  TYVEYLALFK 200
SE-SVA-1033-9C (Ib) 151  RKLYQVEDVE  FEFKEGVVVI  RAGPDGLLNE  FPGGAKLGAV  TYVEYLALFK 200
4p168 (III) 151  RKLYQVEDVE  FEFKEGVVVI  RAGLDGLLNE  FLGGEKLGAV  TYVEYLALFK 200
FA281107 (III) 151  RKLYQVEDVE  FEFKEGVVVI  RAGLDGLLNE  FLGGEKLGAV  TYVEYLA FK 200
(NO-2007-50-385)
DK-3592B (Ia) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SIYAEVDSVL  RRAGQSAIDL 250
M Rhabdo (Ib) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
SE-SVA-14-3D (Ib) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
SE-SVA-14-5G (Ib) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
SE-SVA-1033-3F (Ib) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
SE-SVA-1033-9C (Ib) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
4p168 (III) 201  IINQRAQALL  LTAICQTLEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
FA281107 (III) 201  IINQRAQALL  LTAICQ LEP  DLVPPCSGIL  SVYAEVDSVL  RRAGQSAIDL 250
(NO-2007-50-385)
DK-3592B (Ia) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
M Rhabdo (Ib) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
SE-SVA-14-3D (Ib) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
SE-SVA-14-5G (Ib) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
SE-SVA-1033-3F (Ib) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
SE-SVA-1033-9C (Ib) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQIDDALAS 1000
4p168 (III) 951  NLATEEDAAS  VIKRLARGTL  RGLDI NKKL  ADHIATMDQG  ITQIDDALAS 1000
FA281107 (III) 951  NLATEEDAAS  VIKRLARGTL  RGLDIKNKKL  ADHIATMDQG  ITQID ALAS 1000
(NO-2007-50-385)
DK-3592B (Ia) 1001  ADTINPRIAY  QFRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
M Rhabdo (Ib) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
SE-SVA-14-3D (Ib) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
SE-SVA-14-5G (Ib) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
SE-SVA-1033-3F (Ib) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
SE-SVA-1033-9C (Ib) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
4p168 (III) 1001  ADTINPRIAY  QIRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
FA281107 (III) 1001  ADTINPRIAY  QFRNITDQKE  SEMFVTKFAT  AKTMRMVALS  SSQDVSVVGL 1050
(NO-2007-50-385)
DK-3592B (Ia) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
M Rhabdo (Ib) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
SE-SVA-14-3D (Ib) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
SE-SVA-14-5G (Ib) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
SE-SVA-1033-3F (Ib) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
SE-SVA-1033-9C (Ib) 1101  PLEATRFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
4p168 (III) 1101  PLEATLFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
FA281107 (III) 1101  PLEA LFKLI  DPISWEEEKE  AHHFTIHYYL  SKPSLSSKTA  HTTRGPLVPY 1150
(NO-2007-50-385)
DK-3592B (Ia) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
M Rhabdo (Ib) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
SE-SVA-14-3D (Ib) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
SE-SVA-14-5G (Ib) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
SE-SVA-1033-3F (Ib) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
SE-SVA-1033-9C (Ib) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
4p168 (III) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWRDPKVIF  CTLFDERERI 1650
FA281107 (III) 1601  HQSVPEIITH  PPDLIVVIGG  GLGGCVVPYL  QKWR PKVIF  CTLFDERERI 1650
(NO-2007-50-385)
DK-3592B (Ia) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
M Rhabdo (Ib) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
SE-SVA-14-3D (Ib) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
SE-SVA-14-5G (Ib) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
SE-SVA-1033-3F (Ib) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
SE-SVA-1033-9c (Ib) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
4p168 (III) 1801  SVVQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
FA281107 (III) 1801  S VQAAFRKI  DEKLESESRL  EHSKWSLPEL  PPREKDILLG  YVASVFLKLG 1850
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Figure 2 Partial amino acid alignments of viral proteins from various VHSV isolates. The part shaded red are amino acid substitutions 
between 4p168 as a representative for a non‑virulent VHSV genotype III isolate and NO‑2007‑50‑385 as a representative for a virulent VHSV geno‑
type III isolate to rainbow trout. The part shaded blue (aa 118–123 of the N‑protein) and the part shaded yellow (aa 47 of the G‑protein, aa 108 and 
110 of the Nv‑protein, and aa 1012 of the L‑protein) are referred to in the “Discussion”.
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N-protein region at aa position 118–123 of the virulent 
NO-2007-385-50 (AVNNDS) and the non-virulent 4p168 
(TVNDDN) isolates could be related to virulence of 
VHSV GIII in rainbow trout. That region is the epitopic 
part of mAb VHS-3.75 which shows a different reaction 
pattern between the NO-2007-50-385 and 4p168 isolates 
[22]. Particularly, three aa substitutions at 118 (threo-
nine  →  alanine), 121 (aspartic acid  →  asparagine) and 
123 (asparagine → serine) of the N-protein might be the 
site for causing changes in virulence from low to high for 
rainbow trout. Since the NDS domain (position 121–123 
of virulent isolates) is well known as a N-linked glycosyla-
tion site, molecular conformation of the region of those 
isolates could be very different.
Using reverse genetics, Kim et al. [16] reported that a 
point mutation from I (isoleucine) to F (phenylalanine) at 
position 1092 in the L-protein of GIII and GIVa VHSV 
isolates can increase the virulence in an in  vitro trial. 
Although the aa in position 1012 of NO-2007-50-385 and 
DK-3592B is F, it is I in the GIb isolates SE-SVA-14-3D 
and SE-SVA-1033-3F of medium/high (30–90% mortali-
ties) virulence to rainbow trout [38, 39]. This means that 
although being a candidate, the aa substitution in posi-
tion 1012 of the L-protein clearly is not the only determi-
nant for virulence in rainbow trout.
Judging from the results of the aa alignments, one possi-
bility could be that the Nv-protein participated in virulence. 
Two aa substitutions in the Nv-protein were found in the 
comparative study between 4p168 and NO-2007-50-385. 
One of those, in position 110, is shared between 4p168 and 
DK-3592B isolates, and can therefore not be a singular viru-
lence determinant when applying the same logic than above. 
The other aa substitution in position 108 is more interest-
ing, as both 4p168 and NO-2007-50-385 isolates differ from 
each other and from all other isolates, including DK-3592B. 
A few reports indicate that the Nv-genome of VHSV plays 
an important role in the virulence of GIVa and GIVb [40, 
41]. However, Einer-Jensen et  al. [17] reported that differ-
ences in virulence among phylogenetically distinct isolates 
of VHSV are not explained by variability of the Nv. There-
fore, regarding the virulence to rainbow trout, future studies 
on aa substitutions in Nv are needed to determine its role in 
the virulence of VHSV to that fish species.
One at position 43 in the P-protein and 2 aa substitu-
tions at position 72 and 111 in the M-protein are found 
by comparison of aa alignments. The role of these substi-
tutions in the virulence of VHSV might also need future 
studies.
The DK-3592B and NO-2007-50-385 isolates showed 
high titre in RTG-2 cells, but the titre of 4p168 was low 
in that cell. This result suggests that certain processes 
in viral replication in rainbow trout cells are different 
between NO-2007-50-385 and 4p168.
It may be necessary for VHSV to pass a number 
of barriers before it becomes virulent in rainbow 
trout. The first barrier for the virus is its entry into 
the host cells. The second barrier is its replication 
in the cells. GIa isolates such as DK-3592B can eas-
ily pass through the first barrier, since the G-protein 
may have high affinity to cells of rainbow trout [42]. 
Continuously, it can easily pass to a second barrier, 
since it also can propagate in the rainbow trout cells 
and, as a result, the infected fish dies. Since there is 
only one aa substitution of the G-protein between 
NO-2007-50-385 and 4p168 isolates, it is supposed 
that the intensity of infection of the host cells must 
be similar. Nevertheless, as for the normal genotype 
III viruses such as the 4p168 isolate, the fish does not 
die because it cannot propagate with the same effi-
ciency in rainbow trout. However, NO-2007-50-385 
can propagate in the host cell and thereby kill the 
fish.
The isolation of NO-2007-50-385 might be a result of 
VHSV GIII being present as virus populations composed 
of a cloud of variants in the wild and farm environment. 
Other reports revealed that VHSV GIb isolates might 
become virulent in farmed rainbow trout in marine 
environment [43, 44]. To this regard, marine isolates of 
VHSV may be a potential threat to the farming industry 
if provided with the opportunity to adapt under intensive 
farming conditions.
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